Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1992-09-24
1995-11-21
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514530, 514913, A61K 3119, A61K 31215
Patent
active
054687780
ABSTRACT:
Intraocular pressure is lowered in the eye of a mammal by administration of a pharmaceutical composition containing as active ingredient a compound of the formula ##STR1## where the dotted line represents a bond or the absence of a bond, wavy lines connected to the olefinic bond represent cis or trans configuration about the olefinic bond; R.sub.1 represents H, or CO-R.sub.3 where R.sub.3 is lower alkyl of 1 to 6 carbons, carbocyclic aryl or heterocyclic aryl; or carbocyclic aryl or heteroaryl substituted lower alkyl group; R.sub.2 represents H or lower alkyl of 1 to 6 carbons, and n is an integer between 0 and 8.
REFERENCES:
patent: 3903143 (1975-09-01), Mueller
patent: 4033992 (1977-07-01), Grudzinskas et al.
patent: 4599353 (1986-07-01), Bito
patent: 4822820 (1989-04-01), DeSantis et al.
patent: 4994274 (1991-02-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
Bito, L. Z., Arch. Ophthalmol, 105, 1036 (1987).
Bito, L. Z., Applied Pharmacology in the Medical Treatment of Glaucomas, Drance, S. M. and Neufeld, A. H. eds., New York, Grune & Stratton, 1984 pp. 477-505.
Bito, L. Z., Biological Protection with Prostaglandins, Cohen, M. M., ed., Boca Raton Fla. CRC Press Inc., 1985, pp. 231-252.
M. S. Starr, Exp. Eye Res. 11, 170-177 (1971).
Nilsson et al., Invest, Ophthalmol. Vis. Sci. 28 (suppl), 284 (1987).
Siebold et al., Prodrug 5, 3 (1989).
Woodward, et al., Prostaglandin F.sub.2a Effects on Intraocular Pressure Negatively Correlate with FP-Receptor Stimulation, Investigative Ophthalmology & Visual Science, vol. 30, No. 8, Aug. 1989.
Zajacz, et al., Effect on Human Eye of Prostaglandin and a Prostaglandin Analogue Used to Induce Abortion, The Eye: Reproduction, Obstetrics and Gynecology, 4, 316 (1976).
Burk Robert M.
Chan Ming F.
Garst Michael E.
Roof Michael B.
Allergan Inc.
Baran Robert J.
Fay Zohreh
Szekeres Gabor L.
Voet Martin A.
LandOfFree
Method of lowering intraocular pressure by administering a pharm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of lowering intraocular pressure by administering a pharm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of lowering intraocular pressure by administering a pharm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1137537